| Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 365 (9472), 1687-1717, 2005 | 5550 | 2005 |
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 4600 | 2005 |
| Tamoxifen for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 351 (9114), 1451-1467, 1998 | 3156 | 1998 |
| Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ... Lancet 365 (9453), 60-62, 2005 | 2235 | 2005 |
| Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 … Early Breast Cancer Trialists' Collaborative Group The Lancet 378 (9804), 1707-1716, 2011 | 2024 | 2011 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 1812 | 1998 |
| Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials EBCTC Group The lancet 378 (9793), 771-784, 2011 | 1742 | 2011 |
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC … A The The Lancet 359 (9324), 2131-2139, 2002 | 1556 | 2002 |
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials EBCTC Group The Lancet 379 (9814), 432-444, 2012 | 1272 | 2012 |
| Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 355 (9217), 1757-1770, 2000 | 989 | 2000 |
| Palbociclib in hormone-receptor–positive advanced breast cancer NC Turner, J Ro, F André, S Loi, S Verma, H Iwata, N Harbeck, S Loibl, ... New England Journal of Medicine 373 (3), 209-219, 2015 | 875 | 2015 |
| Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer Early Breast Cancer Trialists' Collaborative Group New England journal of medicine 319 (26), 1681-1692, 1988 | 812 | 1988 |
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer: results of the ATAC … ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group Cancer 98 (9), 1802-1810, 2003 | 692 | 2003 |
| c-erbB2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, ... Journal of Clinical Oncology 14, 2702-2708, 1996 | 525 | 1996 |
| Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer G Di Lorenzo, G Tortora, FP D’Armiento, G De Rosa, S Staibano, ... Clinical Cancer Research 8 (11), 3438-3444, 2002 | 509 | 2002 |
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 498 | 2015 |
| Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials M De Laurentiis, G Cancello, D D'Agostino, M Giuliano, A Giordano, ... Journal of Clinical Oncology 26 (1), 44-53, 2008 | 426 | 2008 |
| Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study G Fontanini, S Vignati, F Basolo, G Bevilacqua, M Lucchi, A Mussi, ... Journal of the National Cancer Institute 89 (12), 881-886, 1997 | 370 | 1997 |
| A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer M De Laurentiis, G Arpino, E Massarelli, A Ruggiero, C Carlomagno, ... Clinical cancer research 11 (13), 4741-4748, 2005 | 367 | 2005 |
| Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin … G Fontanini, M De Laurentiis, S Vignati, S Chinè, M Lucchi, V Silvestri, ... Clinical Cancer Research 4 (1), 241-249, 1998 | 349 | 1998 |
Sabino De PlacidoProfessore Ordinario di Oncologia MedicaVerified email at unina.it
